Delivery Order SPE2DB22D3102-SPE2DB25FL2UK
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.52 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under the company's broader pharmaceutical supply relationships with the federal government. The product will be delivered to AmerisourceBergen's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Latuda 20 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a firm fixed price ceiling value of $46,374.90 and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Latuda 60 mg, a medication used to treat bipolar disorder and schizophrenia, valued at $3,040.56. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Latuda 40 mg tablets. The contract has a ceiling value of $1,193.53 and is a firm fixed-price delivery order with an ultimate completion date of October 11, 2024. It is not set aside for any special program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $3,726.05 to supply 30 packages of 20mg Latuda tablets. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for antipsychotic medication supports the DLA's mission to provide logistics support for all military services and combatant commands....
- The Defense Logistics Agency awarded a $1,520.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 tablets of 20 mg Latuda. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by September 18, 2023. Amerisourcebergen will serve as the prime contractor on the order to provide the Defense Logistics Agency with the specified...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,679 to Amerisourcebergen Drug Corporation for the supply of 30 tablets of 20mg Latuda. The order was placed under an existing Prime Vendor contract vehicle to support the agency's pharmaceutical needs. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16th to August 17th, 2023. No subcontractors or set aside designations were identified. The Defense...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2UKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,999.03 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count packages) on September 2, 2025, with a completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Defense Health Agency and military healthcare systems. The SPE2DX IDC enables the company to supply a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The Defense Logistics Agency is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a key supplier for federal medical supply needs through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 9/2/25 |